| As Of | Filing | | Doc. | | Page | | Title | Docs. |
|---|
| | |  |
| 12/15/23 | | 424B5 | | | | 1 | | About This Prospectus | 1 |
| | | | | | 1 | | About This Prospectus Supplement | 1 |
| | | | | | 1 | | AC Immune SA | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Additional Information | 1 |
| | | | | | 1 | | Advisers | 1 |
| | | | | | 1 | | American depositary shares | 1 |
| | | | | | 1 | | Annual report to security holders | 1 |
| | | | | | 1 | | Arrears and delinquencies | 1 |
| | | | | | 1 | | Attestation report of the registered public accounting firm | 1 |
| | | | | | 1 | | Audit committee financial expert | 1 |
| | | | | | 1 | | Auditors | 1 |
| | | | | | 1 | | Board practices | 1 |
| | | | | | 1 | | Business overview | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Capitalization | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Capitalization and indebtedness | 1 |
| | | | | | 1 | | Change in registrant's certifying accountant | 1 |
| | | | | | 1 | | Changes in internal control over financial reporting | 1 |
| | | | | | 1 | | Code of Ethics | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Comparison of Swiss Law and Delaware Law | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Compensation | 1 |
| | | | | | 1 | | Consolidated Balance Sheets as of December 31, 2023 and 2022 | 1 |
| | | | | | 1 | | Consolidated statements and other financial information | 1 |
| | | | | | 1 | | Consolidated Statements of Cash Flows for the fiscal years ended December 31, 2023, 2022 and 2021 | 1 |
| | | | | | 1 | | Consolidated Statements of Changes in Equity for the fiscal years ended December 31, 2023, 2022 and 2021 | 1 |
| | | | | | 1 | | Consolidated Statements of Income/(Loss) and Consolidated Statements of Comprehensive Income/(Loss) for the fiscal years ended December 31, 2023, 2022 and 2021 | 1 |
| | | | | | 1 | | Controls and Procedures | 1 |
| | | | | | 1 | | Corporate governance | 1 |
| | | | | | 1 | | Critical Accounting Estimates | 1 |
| | | | | | 1 | | Cybersecurity | 1 |
| | | | | | 1 | | Debt securities | 1 |
| | | | | | 1 | | Defaults | 1 |
| | | | | | 1 | | Defaults, Dividend Arrearages and Delinquencies | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Description of Debt Securities | 1 |
| | | | | | 1 | | Description of Purchase Contracts | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Description of Securities Other Than Equity Securities | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Description of Share Capital and Articles of Association | 1 |
| | | | | | 1 | | Description of Subscription Rights | 1 |
| | | | | | 1 | | Description of Units | 1 |
| | | | | | 1 | | Description of Warrants | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Dilution | 2 |
| | | | | | 1 | | Directors and senior management | 1 |
| | | | | | 1 | | Directors, Senior Management and Employees | 1 |
| | | | | | 1 | | Disclosure controls and procedures | 1 |
| | | | | | 1 | | Disclosure of a registrant's action to recover erroneously awarded compensation | 1 |
| | | | | | 1 | | Disclosure regarding foreign jurisdictions that prevent inspections | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Dividend Policy | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Dividends and paying agents | 1 |
| | | | | | 1 | | Documents on display | 1 |
| | | | | | 1 | | Employees | 1 |
| | | | | | 1 | | Exchange controls | 1 |
| | | | | | 1 | | Exemptions from the listing standards for audit committees | 1 |
| | | | | | 1 | | Exhibits | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Expenses | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Expenses of the issue | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Experts | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Financial Information | 1 |
| | | | | | 1 | | Financial statements | 1 |
| | | | | | 1 | | Forward-Looking Statements | 1 |
| | | | | | 1 | | History and development of the company | 1 |
| | | | | | 1 | | Identity of Directors, Senior Management and Advisers | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Incorporation By Reference | 1 |
| | | | | | 1 | | Incorporation of Certain Information by Reference | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Information on the Company | 1 |
| | | | | | 1 | | Insider trading policies | 1 |
| | | | | | 1 | | Interests of experts and counsel | 1 |
| | | | | | 1 | | Key Information | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Legal Matters | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Liquidity and capital resources | 1 |
| | | | | | 1 | | Major shareholders | 1 |
| | | | | | 1 | | Major Shareholders and Related-Party Transactions | 1 |
| | | | | | 1 | | Management's Annual Report on internal control over financial reporting | 1 |
| | | | | | 1 | | Markets | 1 |
| | | | | | 1 | | Material contracts | 1 |
| | | | | | 1 | | Material Modifications to the Rights of Security Holders and Use of Proceeds | 1 |
| | | | | | 1 | | Memorandum and articles of association | 1 |
| | | | | | 1 | | Method and expected timetable | 1 |
| | | | | | 1 | | Mine safety disclosure | 1 |
| | | | | | 1 | | Notes to the Consolidated Financial Statements | 1 |
| | | | | | 1 | | Offer statistics | 1 |
| | | | | | 1 | | Offer Statistics and Expected Timetable | 1 |
| | | | | | 1 | | Offering and listing details | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Offering, The | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Operating and Financial Review and Prospects | 1 |
| | | | | | 1 | | Operating results | 1 |
| | | | | | 1 | | Organizational structure | 1 |
| | | | | | 1 | | Other securities | 1 |
| | | | | | 1 | | Part I | 1 |
| | | | | | 1 | | Part Ii | 1 |
| | | | | | 1 | | Part Iii | 1 |
| | | | | | 1 | | Plan of distribution | 2 |
| 12/15/23 | | 424B5 | | | | 1 | | Presentation of Financial Information | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Principal accountant fees and services | 1 |
| | | | | | 1 | | Property, plant and equipment | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Prospectus Supplement Summary | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Purchases of equity securities by the issuer and affiliated purchasers | 1 |
| | | | | | 1 | | Quantitative and Qualitative Disclosures About Market Risk | 1 |
| | | | | | 1 | | Reasons for the offer and use of proceeds | 1 |
| | | | | | 1 | | Related-party transactions | 1 |
| | | | | | 1 | | Report of independent registered public accounting firm | 1 |
| | | | | | 1 | | Research and development, patents and licenses, etc | 1 |
| | | | | | 1 | | Reserved | 1 |
| | | | | | 1 | | Risk factors | 2 |
| 12/15/23 | | 424B5 | | | | 1 | | S-1 | 1 |
| | | | | | 1 | | S-17 | 1 |
| | | | | | 1 | | S-18 | 1 |
| | | | | | 1 | | S-19 | 1 |
| | | | | | 1 | | S-2 | 1 |
| | | | | | 1 | | S-20 | 1 |
| | | | | | 1 | | S-21 | 1 |
| | | | | | 1 | | S-28 | 1 |
| | | | | | 1 | | S-36 | 1 |
| | | | | | 1 | | S-37 | 1 |
| | | | | | 1 | | S-4 | 1 |
| | | | | | 1 | | S-6 | 1 |
| | | | | | 1 | | S-8 | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Selling shareholders | 1 |
| | | | | | 1 | | Share capital | 1 |
| | | | | | 1 | | Share ownership | 1 |
| | | | | | 1 | | Significant changes | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Special Note Regarding Forward-Looking Statements | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Statement by experts | 1 |
| | | | | | 1 | | Subsidiary information | 1 |
| | | | | | 1 | | Table of Contents | 2 |
| 12/15/23 | | 424B5 | | | | 1 | | Tax Considerations | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Taxation | 1 |
| | | | | | 1 | | the Offer and Listing | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | The Offering | 1 |
| | | | | | 1 | | Trademarks | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Trend information | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Underwriting | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Unresolved Staff Comments | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Use of Proceeds | 1 |
| 3/14/24 | | 20-F | | | | 1 | | Warrants and rights | 1 |
| 12/15/23 | | 424B5 | | | | 1 | | Where You Can Find More Information | 1 |
